|Awarded On||August 17, 2022|
|Title||Clinical Validation of the MiTR-core (Minimally Invasive Targeted Resection) Technology for Early Lung Cancer Intervention|
|Program||Product Development Research|
|Award Mechanism||Seed Awards for Product Development Research|
|Principal Investigator/Program Director||Joanna Nathan|
|Cancer Sites||Lung and Bronchus|
*Pending contract negotiation
Nucore Inc. is a Houston-based medical device company resulting from a multi-year collaboration between J&J's Center for Medical Device Innovation @ The Texas Medical Center and California-based Precision Thoracic to innovate novel technologies focused on the early interception, diagnosis, and treatment of lung cancer. The American Cancer Society notes that "Lung cancer is by far the leading cause of cancer death among both men and women, making up almost 25% of all cancer deaths. More people die of lung cancer than of colon, breast, and prostate cancers combined." One reason that lung cancer is so lethal is that it is usually diagnosed late when it has already spread. There is a desperate...